Quick Answer
Cyclerion Therapeutics, Inc. reported Total Assets of $9.98 million for fiscal year 2025.
Cyclerion Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $9.98M | +4.3% |
| 2024 | $9.57M | -28.4% |
| 2023 | $13.37M | -26.0% |
| 2022 | $18.08M | -69.5% |
| 2021 | $59.33M | -48.6% |
| 2020 | $115.38M | -38.1% |
| 2019 | $186.48M | +2419.6% |
| 2018 | $7.40M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.41M | +17.0% | +11.2% |
| June 30, 2025 | $9.37M | -6.9% | -4.8% |
| March 31, 2025 | $9.85M | -13.3% | +2.8% |
| December 31, 2024 | $9.57M | -28.4% | +7.6% |
| September 30, 2024 | $8.90M | -41.5% | -11.6% |
| June 30, 2024 | $10.06M | -0.3% | -11.4% |
| March 31, 2024 | $11.36M | -0.8% | -15.0% |
| December 31, 2023 | $13.37M | -26.0% | -12.1% |
- Cyclerion Therapeutics, Inc. showed an increase of +4.3% in Total Assets compared to the prior fiscal year.
- Over the 2018–2025 period, Cyclerion Therapeutics, Inc.’s total assets has grown by 34.9% (from $7.40 million to $9.98 million).
- The most recent figure is from Cyclerion Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: